TERC and cancer: Telomerase‐deficient mice presented a drastically reduced incidence in malignant tumors at their time of death compared to Terc+/+ mice (Fig. 3E), in agreement with a potent tumor suppressor activity of short telomeres (Gonzalez‐Suarez et al., 2000).